TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PRLD

Prelude Therapeutics Inc

Healthcare · Biotechnology

3.90$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Prelude Therapeutics Inc (PRLD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 33.9% of the shares are freely tradable; institutional investors hold 67.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 67.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 13.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 33.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 14.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 65Mio.

Largest Shareholders

Institutions

Institutions PRLD
Name Stake (%) Shares Change (%) Date
Orbimed Advisors LLC 13.67 10,909,256 +0.0 03/31/2026
Baker Bros Advisors LP 12.69 10,123,824 +0.0 03/31/2026
Soleus Capital Management, L.P. 4.23 3,378,378 +0.0 06/30/2026
Kynam Capital Management, LP 3.03 2,415,087 +51.6 06/30/2026
Vanguard Capital Management, LLC 1.54 1,230,406 +0.0 03/31/2026
Two Sigma Investments LLC 1.24 993,369 +7.6 06/30/2026
Millennium Management LLC 1.06 844,993 +120.8 06/30/2026
Adage Capital Partners Gp LLC 0.96 766,095 +0.0 06/30/2026

Funds

Funds PRLD
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.90 1,513,825 +0.0 08/31/2026
iShares Russell 2000 ETF 0.81 648,110 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Apr 21, 2026 David P Bonita Director Buy 2,815,315 4.44 12,499,999
Apr 21, 2026 Orbimed Advisors Llc Director Buy 2,815,315 4.44 12,499,999

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?